These interactions between the GR and the ER have an impact on patient outcomes in ER-positive tumours, as higher expression of GR was related to a favourable prognosis, while low GR expression was associated with worse outcomes and high Ki67, p53, and CD71 expression9. The gene discussed is NR3C1; the disease is neoplasm.